GPT-5 and OpenAI Models Expand into Real-World Use from Immunology Research to Travel Platforms

API/서비스 | Wed Jun 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) | 2 sources

GPT-5 Pro helped solve a longstanding immunology puzzle while Omio built a conversational travel platform on OpenAI models.

Analysis

[OpenAI GPT-5 Pro] helped immunologist Derya Unutmaz solve a three-year-old T cell mystery ^[1]

• Used in research by Derya Unutmaz
• professor at Jackson Laboratory and University of Connecticut
• Resolved an unsolved question since 2022 about the relationship between glucose and T cell differentiation
• Analyzed the phenomenon of excessive generation of inflammatory response cells upon deoxyglucose exposure
• Investigated the cause of differences between low-glucose and deoxyglucose environments

[Omio] built a conversational travel platform powered by OpenAI models ^[2]

• Multimodal travel platform connecting over 3
• 000 transportation providers across 47 countries
• Launched initial travel experience through ChatGPT in 2023
• Integrated real-time transportation inventory and pricing data with ChatGPT
• Transitioned from a search-based interface to an AI-native customer experience

[Omio internal operations] transitioned to an AI-native organization through company-wide adoption of ChatGPT and Codex ^[2]

• Deployed ChatGPT to all employees and encouraged experimentation
• Deeply integrated Codex into engineering workflows
• Expanded Codex usage to non-engineering departments
• AI-native transformation led by CTO Tomas Vocetka

Sources

• [1] How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery - OpenAI Blog
• [2] How Omio is building the future of conversational travel - OpenAI Blog